- cafead   May 28, 2024 at 10:42: AM
via Gilead Sciences (NASDAQ:GILD) has agreed to collaborate with Cartography Biosciences to develop new therapies for triple-negative breast cancer and adenocarcinoma, the most common form of non-small cell lung cancer.
article source
article source